“
March 25, 2021
Cattura il respiro / Catch your breath
AIPO* Webinar: 25.03.2021 - 17.00-18.30
Presented by: Dr. Giuseppe Insalaco (IRIB CNR), Dr. Gianluca Botto (ASST Rhodense, Rho & Garbagnate), Dr. Alberto Braghiroli (IRCSS Maugeri)
* AIPO (Associazione Italiana Pneumologi Ospedalieri)
The discrepancy between the epidemiology of respiratory disorders in sleep and the availability of instrumental diagnostics has been a concern of the specialist in this fascinating sector since its inception.
This webinar aims to clarify the areas of relevance of screening and diagnostic paths dedicated mainly to obstructive apneas, to show how in a non-respiratory specialist field such as arrhythmology there are still unsatisfied values of diagnostics and identification of paths to be dedicated to these patients in the face of increasingly convincing evidence of how this can benefit patients.
Dr. Giuseppe Insalaco
Screening e diagnostica dei DRS (SBD screening and diagnostics)
Dr. Gianluca Botto
DRS e (SBD and arrhythmias)
Dr. Alberto Braghiroli
Il dispositivo, il suo funzionamento e come si inserisce nel percorso della diagnostica dei DRS
(The device, its operation and how it fits into the diagnostic path of the SBD)
“
March 12, 2021
World Sleep Day: screening of sleep disorders with Airgo at nine Maugeri Institutes nationwide
Milan - Giornata Mondiale del Sonno: screening dei disturbi del sonno con Airgo in nove Istituti Maugeri - per tutto marzo e fino al 15 aprile 2021, negli Istituti aderenti sarà disponibile anche la nuovissima fascia toracica AirGo, un device testato clinicamente all’IRCCS Maugeri di Veruno.
Throughout March and until April 15, the brand new AirGo chest strap, a platform clinically tested at IRCCS Maugeri in Veruno, will be used for Home Sleep Tests.
“
March 8, 2021
New study validates Airgo excellence in phenotyping patients with mild, moderate, and severe Obstructive Sleep Apnea (OSA)
Milan - a new study using the Airgo Console and Semantic Engine confirms ability to properly assess the occurrence and the severity of respiratory sleep disorders with a 94% positive predictive value and 89% negative predictive value in obstructive sleep apnea (OSA) group.
“
December 21, 2020
MyAir closes A Series funding with Istituti Clinici Scientifici Maugeri SpA SB
Milan - MyAir, Inc., a medtech company based in Boston and Milan specialized in respiratory disease diagnostics, completed the A Series funding round with the entry of ICS Maugeri, for 1 million Euros, in cash and clinical services, aimed at financing the development of new platform functionalities Airgo for breathing monitoring, in continuity with the results already obtained by Maugeri for their patients with Covid or sleep disorders. Maugeri becomes a co-investor with the fund HTH whose entry into the capital of MyAir was announced about a month ago.
Press Release / English version - Italian Version
“
November 10, 2020
MyAir Inc. closes Series A funding with HTH
Milan - MyAir, Inc., a Boston and Milan based digital health company specialized in respiratory diagnostics, has closed its Series A funding round of 1 million Euro with HTH – Health Technology Holding, the proceeds of which will finance the commercial scale up and further development of the Airgo 24/7 Respiratory Monitoring Platform.
Press Release / English version - Italian version